Single gold nanoplasmonic sensor for clinical cancer diagnosis based on specific interaction between nucleic acids and protein

Xingyi Ma, Phuoc Long Truong, Nguyen Hung Anh, Sang Jun Sim

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Plasmonic nanomaterials reveal noble optical properties for next-generation biosensors. Nanoplasmonic biosensors have become simple, sensitive, smart, and consistent with advanced healthcare programs requirements. Notably, an individual nanoparticle analysis can yield unique target information, based on which the next-generation biosensor is revolutionary for end-point detection (single or multiplex), and can be functionally extended to biological phenomena monitoring. Here, we present a single nanoplasmonic sensing technology based on localized surface plasmon resonance for label-free and real-time detection of highly reliable cancer markers (mutant gene and telomerase) in clinical samples. The sensor specifically detects mutant DNA, and can detect telomerase from as few as 10 HeLa cells. This approach can be easily translated to detect other pathological targets with high sensitivity and specificity, and monitor key interactions between biomolecules such as nucleic acids and proteins during disease development in real time. This system has great potential to be further developed for on-chip and simultaneous analysis of multiple targets and interactions.

Original languageEnglish
Pages (from-to)59-65
Number of pages7
JournalBiosensors and Bioelectronics
Volume67
DOIs
Publication statusPublished - 2015 May 5

Fingerprint

Nucleic acids
Biosensing Techniques
Biosensors
Gold
Nucleic Acids
Telomerase
Proteins
Sensors
Biological Phenomena
Neoplasms
Surface Plasmon Resonance
Nanostructures
Environmental Monitoring
Surface plasmon resonance
Biomolecules
HeLa Cells
Nanostructured materials
Nanoparticles
Labels
DNA

Keywords

  • Cancer cell
  • DNA mutation
  • Gold nanoparticle (AuNP)
  • Localized surface plasmon resonance (LSPR)
  • Nanoplasmonic sensor
  • Telomerase activity

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

Single gold nanoplasmonic sensor for clinical cancer diagnosis based on specific interaction between nucleic acids and protein. / Ma, Xingyi; Truong, Phuoc Long; Anh, Nguyen Hung; Sim, Sang Jun.

In: Biosensors and Bioelectronics, Vol. 67, 05.05.2015, p. 59-65.

Research output: Contribution to journalArticle

@article{fb90a2ac1e324803bfd733298c894168,
title = "Single gold nanoplasmonic sensor for clinical cancer diagnosis based on specific interaction between nucleic acids and protein",
abstract = "Plasmonic nanomaterials reveal noble optical properties for next-generation biosensors. Nanoplasmonic biosensors have become simple, sensitive, smart, and consistent with advanced healthcare programs requirements. Notably, an individual nanoparticle analysis can yield unique target information, based on which the next-generation biosensor is revolutionary for end-point detection (single or multiplex), and can be functionally extended to biological phenomena monitoring. Here, we present a single nanoplasmonic sensing technology based on localized surface plasmon resonance for label-free and real-time detection of highly reliable cancer markers (mutant gene and telomerase) in clinical samples. The sensor specifically detects mutant DNA, and can detect telomerase from as few as 10 HeLa cells. This approach can be easily translated to detect other pathological targets with high sensitivity and specificity, and monitor key interactions between biomolecules such as nucleic acids and proteins during disease development in real time. This system has great potential to be further developed for on-chip and simultaneous analysis of multiple targets and interactions.",
keywords = "Cancer cell, DNA mutation, Gold nanoparticle (AuNP), Localized surface plasmon resonance (LSPR), Nanoplasmonic sensor, Telomerase activity",
author = "Xingyi Ma and Truong, {Phuoc Long} and Anh, {Nguyen Hung} and Sim, {Sang Jun}",
year = "2015",
month = "5",
day = "5",
doi = "10.1016/j.bios.2014.06.038",
language = "English",
volume = "67",
pages = "59--65",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Single gold nanoplasmonic sensor for clinical cancer diagnosis based on specific interaction between nucleic acids and protein

AU - Ma, Xingyi

AU - Truong, Phuoc Long

AU - Anh, Nguyen Hung

AU - Sim, Sang Jun

PY - 2015/5/5

Y1 - 2015/5/5

N2 - Plasmonic nanomaterials reveal noble optical properties for next-generation biosensors. Nanoplasmonic biosensors have become simple, sensitive, smart, and consistent with advanced healthcare programs requirements. Notably, an individual nanoparticle analysis can yield unique target information, based on which the next-generation biosensor is revolutionary for end-point detection (single or multiplex), and can be functionally extended to biological phenomena monitoring. Here, we present a single nanoplasmonic sensing technology based on localized surface plasmon resonance for label-free and real-time detection of highly reliable cancer markers (mutant gene and telomerase) in clinical samples. The sensor specifically detects mutant DNA, and can detect telomerase from as few as 10 HeLa cells. This approach can be easily translated to detect other pathological targets with high sensitivity and specificity, and monitor key interactions between biomolecules such as nucleic acids and proteins during disease development in real time. This system has great potential to be further developed for on-chip and simultaneous analysis of multiple targets and interactions.

AB - Plasmonic nanomaterials reveal noble optical properties for next-generation biosensors. Nanoplasmonic biosensors have become simple, sensitive, smart, and consistent with advanced healthcare programs requirements. Notably, an individual nanoparticle analysis can yield unique target information, based on which the next-generation biosensor is revolutionary for end-point detection (single or multiplex), and can be functionally extended to biological phenomena monitoring. Here, we present a single nanoplasmonic sensing technology based on localized surface plasmon resonance for label-free and real-time detection of highly reliable cancer markers (mutant gene and telomerase) in clinical samples. The sensor specifically detects mutant DNA, and can detect telomerase from as few as 10 HeLa cells. This approach can be easily translated to detect other pathological targets with high sensitivity and specificity, and monitor key interactions between biomolecules such as nucleic acids and proteins during disease development in real time. This system has great potential to be further developed for on-chip and simultaneous analysis of multiple targets and interactions.

KW - Cancer cell

KW - DNA mutation

KW - Gold nanoparticle (AuNP)

KW - Localized surface plasmon resonance (LSPR)

KW - Nanoplasmonic sensor

KW - Telomerase activity

UR - http://www.scopus.com/inward/record.url?scp=84922275717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922275717&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2014.06.038

DO - 10.1016/j.bios.2014.06.038

M3 - Article

C2 - 24996253

AN - SCOPUS:84922275717

VL - 67

SP - 59

EP - 65

JO - Biosensors

JF - Biosensors

SN - 0956-5663

ER -